iRhythm Holdings, Inc. (IRTC)
Thursday, November 5, 2026
Key stats
Chart
Price, buy and sell signals and key levels on one chart.
Past 1Y
MA21MA180
SignalsBuyEarly buySellEarly sellTurning pointsSwing highSwing low
Up dayDown day
Thursday, November 5, 2026
Price, buy and sell signals and key levels on one chart.
iRhythm (IRTC) closed at $112.60 on Sep 28, 2026, up 2.0% on the day. The stock is down 3.2% over the past month, down 4.9% over three months, down 36.5% year to date and down 34.1% over the past year (since Sep 26, 2025). It trades 41.5% below its 52-week high of $192.47 and 11.7% above its 52-week low of $100.85. The close sits below its 50-day moving average ($118.10) and below its 200-day moving average ($129.75).
IRTC is scheduled to report earnings on Nov 5, 2026, after market close. Over its last 8 reports the stock moved an average of 7.8% on the first trading day after earnings, beating the options-implied move in 2 of 8.
iRhythm is scheduled to report on Nov 5, 2026, after market close.
Over the last 8 reports, IRTC moved an average of 7.8% on the first trading day after earnings. The move beat the options-implied move in 2 of 8 reports.
No — the Sep 28, 2026 close of $112.60 is 13.2% below the 200-day average of $129.75.
IRTC closed 41.5% below its 52-week high of $192.47.
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with BioIS to develop and commercialize pulse oximetry, accelerometry, and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring products and services. The company was formerly known as iRhythm Technologies, Inc. and changed its name to iRhythm Holdings, Inc. in January 2026. iRhythm Holdings, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.